Furthermore ARID1A, p53 and ß-Catenin turned out to be three promising prognostic factors showing significant differences in independent survival analysis, indicating that ARID1A, p53 and ß-Catenin could be used along traditional clinical and morphologic factors to predict the prognosis of patients with clear cell and endometrioid ovarian and uterine cancer. This evidence concerns the gene TP53 and uterine cancer.